Clinerion Expands in Georgia
The Medison network of clinics, Tbilisi, Georgia, has joined Clinerion’s Patient Network Explorer platform, bringing their patients access to treatments and therapies.
Patients at Medison’s network of clinics will gain access to treatments and therapies by being matched to international clinical trials.
The Medison network of clinics specializes in outpatient and dental services for all social strata. The four clinics in Tbilisi, Georgia, provide medical care to over 6,000 patients each month.
The network has specialist clinical staff and is fully equipped for clinical trials. Medison currently has several trials running.
“We are very happy to have the opportunity to support more patients in Georgia via partnership with Medison,”says Ian Rentsch, CEO of Clinerion. “We look forward to drawing more trials to the country.”
Learn more at www.clinerion.com
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ethical, Biosafety, and Scientific Review Considerations in Hematology and Oncology Clinical Trials
September 10th 2024The current oncology and hematology drug development pipeline features a wide array of large molecule therapeutics. As a result, clinical trial protocols have grown more complex, requiring sponsors, CROs, and research sites to tackle a variety of challenges that were less common with older, more traditional therapies.
